Synopsis of recent research by authors named "Can-Xuan Li"
- Can-Xuan Li's research primarily focuses on the role of long noncoding RNAs and specific genes in the prognosis and treatment of bladder cancer and clear cell renal cell carcinoma, indicating a significant interest in cancer biology and therapeutic targets.
- Significant findings include the identification of a novel necroptosis-related long noncoding RNA signature for bladder cancer prognosis and the discovery of dysregulated plexins as potential therapeutic targets in kidney renal clear cell carcinoma.
- Li's studies also highlight the potential of biomarkers like IQGAP3 and CARS in clear cell renal cell carcinoma to predict clinical outcomes and their association with tumor immunity, enhancing the understanding of cancer mechanisms and guiding future therapeutic strategies.